146 related articles for article (PubMed ID: 1840082)
1. Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP.
Morimoto K; Katayama K; Inoue K; Sato K
Pharmacol Biochem Behav; 1991 Dec; 40(4):893-9. PubMed ID: 1840082
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of inhibition with perforant path kindling: an NMDA-receptor dependent process.
Gilbert ME
Brain Res; 1991 Nov; 564(1):109-16. PubMed ID: 1838018
[TBL] [Abstract][Full Text] [Related]
3. The NMDA antagonist MK-801 suppresses behavioral seizures, augments afterdischarges, but does not block development of perforant path kindling.
Gilbert ME
Epilepsy Res; 1994 Feb; 17(2):145-56. PubMed ID: 8194510
[TBL] [Abstract][Full Text] [Related]
4. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
Wlaź P; Ebert U; Potschka H; Löscher W
Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
[TBL] [Abstract][Full Text] [Related]
5. The role of NMDA receptors in epilepsy: I. Effects of NMDA receptor antagonists (CPP and MK-801) on amygdala kindling in rats.
Katayama K; Morimoto K; Sato K; Ohnishi M; Okamoto M; Otsuki S
Jpn J Psychiatry Neurol; 1990 Jun; 44(2):451-2. PubMed ID: 2147961
[No Abstract] [Full Text] [Related]
6. Inhibitory effect of MK-801 (noncompetitive NMDA receptor antagonist) on kindling-induced synaptic potentiation in acutely prepared rabbits.
Jibiki I; Fujimoto K; Kubota T; Yamaguchi N
Pharmacol Biochem Behav; 1991 Jan; 38(1):163-8. PubMed ID: 1826786
[TBL] [Abstract][Full Text] [Related]
7. Functional alterations in the dentate gyrus after induction of long-term potentiation, kindling, and mossy fiber sprouting.
Golarai G; Sutula TP
J Neurophysiol; 1996 Jan; 75(1):343-53. PubMed ID: 8822562
[TBL] [Abstract][Full Text] [Related]
8. The role of NMDA receptors in epilepsy: II. Effects of NMDA receptor antagonists (CPP and MK-801) on hippocampal long-term potentiation in anesthetized rats.
Morimoto K; Katayama K; Sato K; Ohnishi M; Okamoto M; Otsuki S
Jpn J Psychiatry Neurol; 1990 Jun; 44(2):453-4. PubMed ID: 2175367
[No Abstract] [Full Text] [Related]
9. The NMDA antagonist, MK-801, suppresses long-term potentiation, kindling, and kindling-induced potentiation in the perforant path of the unanesthetized rat.
Gilbert ME; Mack CM
Brain Res; 1990 Jun; 519(1-2):89-96. PubMed ID: 2204470
[TBL] [Abstract][Full Text] [Related]
10. NMDA receptor-dependent plasticity of granule cell spiking in the dentate gyrus of normal and epileptic rats.
Lynch M; Sayin U; Golarai G; Sutula T
J Neurophysiol; 2000 Dec; 84(6):2868-79. PubMed ID: 11110816
[TBL] [Abstract][Full Text] [Related]
11. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures.
Dürmüller N; Craggs M; Meldrum BS
Epilepsy Res; 1994 Feb; 17(2):167-74. PubMed ID: 8194512
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
Sato K; Morimoto K; Okamoto M
Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
[TBL] [Abstract][Full Text] [Related]
13. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
[TBL] [Abstract][Full Text] [Related]
14. NMDA receptor complex and kindling mechanisms.
Morimoto K; Sato M
Epilepsy Res Suppl; 1992; 9():297-305. PubMed ID: 1337443
[No Abstract] [Full Text] [Related]
15. The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures.
Holmes KH; Bilkey DK; Laverty R; Goddard GV
Brain Res; 1990 Jan; 506(2):227-35. PubMed ID: 1967965
[TBL] [Abstract][Full Text] [Related]
16. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
Gilbert ME
Brain Res; 1988 Oct; 463(1):90-9. PubMed ID: 2848609
[TBL] [Abstract][Full Text] [Related]
17. Kindling induces transient NMDA receptor-mediated facilitation of high-frequency input in the rat dentate gyrus.
Behr J; Heinemann U; Mody I
J Neurophysiol; 2001 May; 85(5):2195-202. PubMed ID: 11353034
[TBL] [Abstract][Full Text] [Related]
18. NMDA-dependent currents in granule cells of the dentate gyrus contribute to induction but not permanence of kindling.
Sayin ; Rutecki P; Sutula T
J Neurophysiol; 1999 Feb; 81(2):564-74. PubMed ID: 10036260
[TBL] [Abstract][Full Text] [Related]
19. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
[TBL] [Abstract][Full Text] [Related]
20. Kindling-induced potentiation of excitatory and inhibitory inputs to hippocampal dentate granule cells. II. Effects of the NMDA antagonist MK-801.
Robinson GB
Brain Res; 1991 Oct; 562(1):26-33. PubMed ID: 1799870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
